1. Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Cathet Cardiovasc Interv 2014; 83: 212-20.
2.
Fanelli F, Cannavale A, Gazzetti M, et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol 2014; 37: 898-907.
3.
Mori S, Takahara M, Nakama T, et al. Impact of calcification on clinical outcomes after drug-coated balloon angioplasty for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. Catheter Cardiovasc Interv 2023; 101: 892-9.
4.
Tzafriri AR, Garcia-Polite F, Zani B, et al. Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis. J Control Release 2017; 264: 203-10.
5.
McKinsey JF, Zeller T, Rocha-Singh KJ, et al. Lower extremity revascularization using directional atherectomy. 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv 2014; 7: 923-33.
6.
Shammas NW. How much debulking with atherectomy is enough when treating infrainguinal arterial interventions? The balance between residual stenosis and adventitial injury. Vasc Health Risk Manag 2022; 18: 211-8.
7.
Lichtenberg M, Korosoglou G. Atherectomy plus antirestenotic therapy for SFA lesions: evolving evidence for better patency rates in complex lesions. J Cardiovasc Surg 2019; 60: 205-11.
8.
Baig M, Kwok M, Aldairi A, et al. Intravascular lithotripsy vs atherectomy in the treatment of calcified common femoral artery disease. J Soc Cardiovasc Angiogr Interv 2022; 1: 100374.
9.
Tsutsui RS, Campbell J. Peripheral matters. Intravascular lithotripsy: a new atherectomy option. American College of Cardiology. Cardiology Magazine. Nov. 22, 2019.
10.
Brodmann M, Werner M, Holden A, et al. Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: results of Disrupt PAD II. Catheter Cardiovasc Interv 2019; 93: 335-42.
11.
Brodmann M, Holden A, Zeller T. Safety and feasibility of intravascular lithotripsy for treatment of below-the-knee arterial stenoses. J Endovasc Ther 2018; 25: 499-503.
12.
Tepe G, Brodmann M, Werner M, et al. Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized Disrupt PAD III Trial. JACC Cardiovasc Interv 2021; 14: 1352-61.
13.
Kim ESH, Sharma AM, Scissons R, et al. Interpretation of peripheral arterial and venous Doppler waveforms: a consensus statement from the Society for Vascular Medicine and Society for Vascular Ultrasound. J Vasc Ultrasound 2020; 44: 118-43.
14.
Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26: 517-38.
15.
Stoner MC, Calligaro KD, Chaer RA, et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg 2016; 64: e1-21.
16.
Patel MR, Conte MS, Cutlip DE, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 2015; 65: 931-41.
17.
Sacks D, Marinelli DL, Martin LG, et al. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc and Interv Radiol 2003; 14: 395-404.
18.
Zeller T. Impact of lithoplasty: disrupt PAD. Abstract presented at: VIVA 2016; September 18–22, 2016, Las Vegas, NV, USA.
19.
Brodmann M, Werner M, Brinton TJ, et al. Safety and performance of lithoplasty for treatment of calcified peripheral artery lesions. J Am Coll Cardiol 2017; 70: 908-10.
20.
Tepe G, Brodmann M, Bachinsky W, et al. Intravascular lithotripsy for peripheral artery calcification: mid-term outcomes from the randomized disrupt PAD III Trial. J Soc Cardiovasc Angiogr Interv 2022; 1: 100341.
21.
Stavroulakis K, Bisdas T, Torsello G, et al. Intravascular lithotripsy and drug-coated balloon angioplasty for severely calcified femoropopliteal arterial disease. J Endovasc Ther 2023; 30: 106-13.
22.
Baig M, Kwok M, Aldairi A, et al. Endovascular intravascular lithotripsy in the treatment of calcific common femoral artery disease: a case series with an 18-month follow-up. Cardiovasc Revasc Med 2022; 43: 80-4.
23.
Aftanski P, Thieme M, Klein F, et al. Intravascular lithotripsy in calcified peripheral lesions: single-center JEN-experience. Int J Angiol 2022; 32: 11-20.
24.
Colacchio EC, Salcuni M, Gasparre A, et al. Midterm results of intravascular lithotripsy for severely calcified common femoral artery occlusive disease: a single-center experience. J Endovasc Ther 2023; 30: 859-66.
25.
Nugteren MJ, Hazenberg CEVB, Akkersdijk GP et al. Twelve-month outcomes of intravascular lithotripsy for treatment of calcified popliteal and infrapopliteal lesions in patients with chronic limb–threatening ischemia. J Endovasc Ther 2025; 32: 1127-34.
